Table 1.
Patient characteristics for those with an INR >8 in 2019 and 2020.
Patient characteristics |
2020 n = 30 |
2019 n = 6 |
||
---|---|---|---|---|
n | % | n | % | |
Gender (male) | 16 | 53 | 4 | 67 |
Age (years), mean [sd] | 71 [14.5) | – | 70 [16.7] | – |
Ethnicity | ||||
White | 16 | 53 | 4 | 67 |
Black | 8 | 27 | 2 | 33 |
Hispanic | 4 | 13 | – | – |
Asian | 2 | 7 | – | – |
Care home resident | 3 | 10 | 1 | 17 |
Indication for anticoagulation | ||||
AF | 12 | 40 | – | – |
APS | 2 | 7 | – | – |
VTE⁎ | 8 | 27 | 6 | 100 |
LV Thrombus | 2 | 7 | – | – |
Aortic valve replacement | 2 | 7 | – | – |
Mitral valve replacement | 1 | 3 | – | – |
CVA embolic | 2 | 7 | – | – |
INR target range | ||||
2–3 | 26 | 87 | 3 | 50 |
2.5–3.5 | 2 | 7 | 3 | 50 |
3–4 | 2 | 7 | – | – |
Abbreviations: AF, atrial fibrillation; APS, antiphospholipid syndrome; VTE, venous thromboembolism; LV, left ventricular thrombus; CVA, cerebral vascular accident; SD, standard deviation.
Included DVT, PE, renal vein thrombosis, cerebral sinus vein thrombosis, portal vein thrombosis.